psalexa
logo

Animal Antimicrobials and Antibiotics Market

Global Animal Antimicrobials and Antibiotics Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: CP10535
Available Format:

The global animal antimicrobials and antibiotics market is growing significantly due to the increasing companion animal ownership, large scale livestock production, and high incidences of animal diseases outbreaks. The increasing demand for pet animals and massive unexplored market in the emerging economies, such as India and China are creating ample opportunities for the growth of the global animal antimicrobials and antibiotics market, at a considerable rate in the coming years. The advanced research and development facilities, and new drug developments by the key players are propelling the demand for effective treatment of animal diseases.

Antimicrobials refer to all agents or substances that kill or act against micro-organisms; whereas, antibiotics are type of antimicrobials that are mostly effective against bacteria. Animals are at higher risk of developing and spreading microbial diseases. Therefore, antimicrobials and antibiotics are used for effective treatment of animal diseases.

Based on animal type, the global animal antimicrobials and antibiotics market can be categorized as companion animals, food producing animals, and others animals. The food producing animal segment leads the animal the global animal antimicrobials and antibiotics market. The major reason for its largest share is the increasing livestock production.

Based on mode of administration, the animal antimicrobials and antibiotics market can be categorized, as oral powders and solutions, premixes, intramammary preparations, injections, and other mode of administration. The premixes segment leads the global antimicrobials and antibiotics market.

The global animal antimicrobials and antibiotics market can be categorized on the basis of product type as penicillins, tetracyclines, macrolides, cephalosporins, aminoglycosides, sulfonamides, and others. The tetracyclines category holds the largest market among all the products of the global antimicrobials and antibiotics market.

Some of the factors driving the growth of the global animal antimicrobials and antibiotics market are increasing demand for livestock products, growing companion animal ownership, up surging incidences of animal diseases outbreak, and increasing awareness about animal diseases. In addition, several government and non-government organizations have developed early warning systems for most of the animal diseases; fueling the growth of the global animal antimicrobials and antibiotics market. However, stringent regulatory approvals, and increasing usage of antibiotics alternatives such as feed-enzymes and probiotics are some of the factors restraining the growth of the global animal antimicrobials and antibiotics market to some extent.

Geographically, North America leads the global animal antimicrobials and antibiotics market, due to high incidences of animal diseases outbreak, excessive livestock product consumption, high companion animal ownership, and increased awareness for animal diseases outbreaks. In addition, the major players of the animal antimicrobials and antibiotics market in North America are investing huge capital for the development of drugs for animal diseases. Asia-Pacific is the fastest growing region in the global animal antimicrobials and antibiotics market. The fastest growth of the region is attributed to increasing livestock population, growing demand for animal antimicrobials, and high incidences of animal diseases. Moreover, the Asia-Pacific animal antimicrobials and antibiotics market is growing, due to increasing disposable income and companion animal ownership, and increasing government involvement in countering animal diseases outbreaks in the emerging countries, such as India and China.

Some of the major players operating in the global animal antimicrobials and antibiotics market are Bayer AG, Vibrac, Merck & Co. Inc., Vétoquinol, Ceva, Novartis AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Sanofi, and Zoetis.

 

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of segments
  • Highlights the competitive scenario of the market and major competitors
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry